Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Patrizia Carrieri

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Addiction (Abingdon, England)|April 21, 2010
Commentary on Uhlmann et al. (2010): managing HIV in drug users--the huge gap remaining between evidence and international policy and practiceM Patrizia Carrieri, Alex Wodak
Lancet (London, England)|August 12, 2008
Harm reduction and control of HIV in IDUs in FranceM Patrizia Carrieri, Bruno Spire
Addiction (Abingdon, England)|July 21, 2010
Universal hepatitis B virus vaccination in French prisons: breaking down the last barriersM Patrizia Carrieri, Dominique Rey, Laurent Michel
Harm Reduction Journal|May 23, 2008
Harm reduction and equity of access to care for French prisoners: a reviewLaurent Michel, M Patrizia Carrieri, Alex Wodak
Lancet (London, England)|July 24, 2010
Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forwardDaniel Wolfe, M Patrizia Carrieri, Donald Shepard
The International Journal on Drug Policy|August 11, 2007
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST)Bruno Spire, Gregory M Lucas, M Patrizia Carrieri
Drug and Alcohol Review|May 7, 2011
Reducing harm from injecting pharmaceutical tablet or capsule material by injecting drug usersPerrine Roux, M Patrizia Carrieri, Lenneke Keijzer, et al.
Archives of Internal Medicine|September 30, 2010
Chocolate intake, depression, and clinical progression in HIV-HCV coinfected patients: still more questions than answersM Patrizia Carrieri, Julien Cohen, Maria Winnock, et al.
Journal of Hepatology|September 6, 2011
Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIHM Patrizia Carrieri, Julien Cohen, Dominique Salmon-Ceron, et al.
Lancet (London, England)|May 3, 2011
Concerns about injectable naltrexone for opioid dependenceDaniel Wolfe, M Patrizia Carrieri, Nabarun Dasgupta, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Addiction (Abingdon, England)|April 21, 2010
Commentary on Uhlmann et al. (2010): managing HIV in drug users--the huge gap remaining between evidence and international policy and practiceM Patrizia Carrieri, Alex Wodak
Lancet (London, England)|August 12, 2008
Harm reduction and control of HIV in IDUs in FranceM Patrizia Carrieri, Bruno Spire
Addiction (Abingdon, England)|July 21, 2010
Universal hepatitis B virus vaccination in French prisons: breaking down the last barriersM Patrizia Carrieri, Dominique Rey, Laurent Michel
Harm Reduction Journal|May 23, 2008
Harm reduction and equity of access to care for French prisoners: a reviewLaurent Michel, M Patrizia Carrieri, Alex Wodak
Lancet (London, England)|July 24, 2010
Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forwardDaniel Wolfe, M Patrizia Carrieri, Donald Shepard
The International Journal on Drug Policy|August 11, 2007
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST)Bruno Spire, Gregory M Lucas, M Patrizia Carrieri
Drug and Alcohol Review|May 7, 2011
Reducing harm from injecting pharmaceutical tablet or capsule material by injecting drug usersPerrine Roux, M Patrizia Carrieri, Lenneke Keijzer, et al.
Archives of Internal Medicine|September 30, 2010
Chocolate intake, depression, and clinical progression in HIV-HCV coinfected patients: still more questions than answersM Patrizia Carrieri, Julien Cohen, Maria Winnock, et al.
Journal of Hepatology|September 6, 2011
Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIHM Patrizia Carrieri, Julien Cohen, Dominique Salmon-Ceron, et al.
Lancet (London, England)|May 3, 2011
Concerns about injectable naltrexone for opioid dependenceDaniel Wolfe, M Patrizia Carrieri, Nabarun Dasgupta, et al.
Pageof 3